Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00536692 · ClinicalTrials.gov registry record · Phase 2
Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)
A Phase 2 study, sponsored by CoMentis.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00536692: Completed Phase 2 study, sponsored by CoMentis.
NCT00536692 is a Phase 2 study that has completed, run by CoMentis. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00536692, a Phase 2 study, has completed, sponsored by CoMentis.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
This is an open-label study evaluating the safety and tolerability of topical ocular mecamylamine given twice a day in patients with diabetic macular edema (DME). Patients will be treated for 12 weeks.
Interventions
- DRUG mecamylamine
Trial Details
| Field | Value |
|---|---|
| Start Date | 2007-09 |
| Est. Completion | 2008-04 |
| Phase | Phase 2 |
What the finished NCT00536692 record still lists
NCT00536692 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which mecamylamine is the first listed.
NCT00536692 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00536692 about?
NCT00536692 is a clinical study titled "Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)". This is an open-label study evaluating the safety and tolerability of topical ocular mecamylamine given twice a day in patients with diabetic macular edema (DME). Patients will be treated for 12 weeks.
What is the current status of trial NCT00536692?
This trial is currently completed. It is a Phase 2 study. The study started on 2007-09. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00536692?
The interventions under investigation include: mecamylamine (DRUG).
Who is sponsoring clinical trial NCT00536692?
This trial is sponsored by CoMentis, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia